This article is more than 5 years old. Information may no longer be current.

UPDATE: Mazzo placed on administrative leave following indictment

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Versant Ventures has confirmed that James V. Mazzo, former CEO of Advanced Medical Optics, has been placed on administrative leave following a grand jury indictment on insider trading charges.

“Upon learning of the indictment of Mr. Mazzo, Versant and Mr. Mazzo have mutually agreed that he will suspend any activities as a Versant operating partner until he has resolved the legal matters. We have no other comment,” William J. Link, PhD, Managing Director of Versant Ventures, wrote in an email to Ocular Surgery News.

On Sept. 26, the U.S. Department of Justice announced that Mazzo was indicted on 13 counts of insider trading, 13 counts of tender offer fraud and one count of securities fraud.

His indictment was added to the initial 2012 indictment that named former professional baseball player, Douglas V. DeCinces, and his two associates David Parker and Fred Scott Jackson.

UPDATE: Following the news of his leave of absence from Versant, an Acufocus spokesperson told Healio.com that there has not been and will not be any change regarding Mazzo's status with the company. We will provide any additional updates as information becomes available.